CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process

Journal of Immunology

Volumn 181, Issue 9, 2008, Pages 6384-6393

  Wu, Yu ^a   Li, Ying Yi ^a   Matsushima, Kouji ^b   Baba, Tomohisa ^a   Mukaida, Naofumi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GELATINASE B; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; SCATTER FACTOR; CCL3 PROTEIN, MOUSE; CCR1 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR1; IMMUNOLOGICAL ADJUVANT; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL INFILTRATION; CELL MIGRATION; CHIMERA; CONTROLLED STUDY; FEMALE; FIBROBLAST; IN VITRO STUDY; KIDNEY CARCINOMA; LEUKOCYTE; LUNG METASTASIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUNG TUMOR; MALE; METABOLISM; METASTASIS; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VASCULARIZATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL3; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; LEUKOCYTES; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CCR1; RECEPTORS, CCR5;

EID: 58749093606     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.9.6384     Document Type: Article

References (54)

1. Eccles, S. A., and D. R. Welch. 2007. Metastasis: recent discoveries and novel treatment strategies. Lancet 369: 1742-1757. (Pubitemid 46755391)
2. Deryugina, E. I., and J. P. Quigley. 2006. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25: 9-34.
3. Sugimoto, Y., M. Watanabe, T. Oh-hara, S. Sato, T. Isoe, and T. Tsuruo. 1991. Suppression of experimental lung colonization of a metastatic variant of murine colon adenocarcinoma 26 by a monoclonal antibody 8F11 inhibiting tumor cell-induced platelet aggregation. Cancer Res. 51: 921-925.
4. Giraudo, E., M. Inoue, and D. Hanahan. 2004. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J. Clin. Invest. 114: 623-633. (Pubitemid 39578752)
5. Cavallaro, U., and G. Christofori. 2001. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim. Biophys. Acta 1552: 39-45. (Pubitemid 34066627)
6. Kim, K. J., B. Li, J. Winer, M. Armanini, N. Gillett, H. S. Phillips, and N. Ferrara. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844. (Pubitemid 23132159)
7. Takahashi, Y., Y. Kitadai, C. D. Bucana, K. R. Cleary, and L. M. Ellis. 1995. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 55: 3964-3968.
8. Dvorak, H. F. 2002. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J. Clin. Oncol. 20: 4368-4380.
9. Akbulut, H., F. Altuntas, K. G. Akbulut, G. Ozturk, M. Cindoruk, E. Unal, and F. Icli. 2002. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma. Cytokine 20: 184-190. (Pubitemid 37163470)
10. Arbeit, J. M., D. C. Olson, and D. Hanahan. 1996. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carcinogenesis in K14-HPV16 transgenic mice. Oncogene 13: 1847-1857.
11. Matsumoto, K., and T. Nakamura. 2006. Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int. J. Cancer 119: 477-483. (Pubitemid 43955698)
12. Balkwill, F., and A. Mantovani. 2001. Inflammation and cancer: back to Virchow? Lancet 357: 539-545. (Pubitemid 32173595)
13. Nozawa, H., C. Chiu, and D. Hanahan. 2006. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. USA 103: 12493-12498. (Pubitemid 44267286)
14. Schmid, M. C., and J. A. Varner. 2007. Myeloid cell trafficking and tumor angiogenesis. Cancer Lett. 250: 1-8.
15. Hart, I. R., and I. J. Fidler. 1980. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res. 40: 2281-2287.
16. Koshkina, N. V., J. C. Waldrep, L. E. Roberts, E. Golunski, S. Melton, and V. Knight. 2001. Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model. Clin. Cancer Res. 7: 3258-3262.
17. Tomita, Y., X. Yang, Y. Ishida, Y. Nemoto-Sasaki, T. Kondo, M. Oda, G. Watanabe, G. N. Chaldakov, C. Fujii, and N. Mukaida. 2004. Spontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55. Int. J. Cancer 112: 927-933. (Pubitemid 39506997)
18. Murphy, P. M., M. Baggiolini, I. F. Charo, C. A. Hebert, R. Horuk, K. Matsushima, L. H. Miller, J. J. Oppenheim, and C. A. Power. 2000. International union of pharmacology: XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52: 145-176.
19. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES. MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958. (Pubitemid 26234510)
20. Boring, L., J. Gosling, F. S. Monteclaro, A. J. Lusis, C. L. Tsou, and I. F. Charo. 1996. Molecular cloning and functional expression of murine JE (monocyte chemoattractant protein 1) and murine macrophage inflammatory protein 1α receptors: evidence for two closely linked C-C chemokine receptors on chromosome 9. J. Biol. Chem. 271: 7551-7558. (Pubitemid 26107031)
21. Ishida, Y., A. Kimura, T. Kondo, T. Hayashi, M. Ueno, N. Takakura, K. Matsushima, and N. Mukaida. 2007. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. Am. J. Pathol. 170: 843-854. (Pubitemid 47339354)
22. + T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J. Clin. Invest. 104: 49-57.
23. Murai, M., H. Yoneyama, T. Ezaki, M. Suematsu, Y. Terashima, A. Harada, H. Hamada, H. Asakura, H. Ishikawa, and K. Matsushima. 2003. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat. Immunol. 4: 154-160. (Pubitemid 36193017)
24. Gao, J. L., T. A. Wynn, Y. Chang, E. J. Lee, H. E. Broxmeyer, S. Cooper, H. L. Tiffany, H. Westphal, J. Kwon-Chung, and P. M. Murphy. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185: 1959-1968.
25. Huss, W. J., C. F. Hanrahan, R. J. Barrios, J. W. Simons, and N. M. Greenberg. 2001. Angiogenesis and prostate cancer: identification of a molecular progression switch. Cancer Res. 61: 2736-2743. (Pubitemid 32685863)
26. Li, Y., T. Aoki, Y. Mori, M. Ahmad, H. Miyamamori, T. Takino, and H. Sato. 2004. Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar. Cancer Res. 64: 7058-7064. (Pubitemid 39331017)
27. Loetscher, P., M. Uguccioni, L. Bordoli, M. Baggiolini, B. Moser, C. Chizzolini, and J. M. Dayer. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature 391: 344-345.
28. Ubogu, E. E., M. K. Callahan, B. H. Tucky, and R. M. Ransohoff. 2006. CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro. Cell. Immunol. 243: 19-29.
29. Garcia-Vicuna, R., M. V. Gomez-Gaviro, M. J. Dominguez-Luis, M. K. Pec, I. Gonzalez-Alvaro, J. M. Alvaro-Gracia, and F. Diaz-Gonzalez. 2004. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum. 50: 3866-3877. (Pubitemid 39643933)
30. Horak, E. R., R. Leek, N. Klenk, S. LeJeune, K. Smith, N. Stuart, M. Greenall, K. Stepniewska, and A. L. Harris. 1992. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124.
31. Fang, J., Y. Shing, D. Wiederschain, L. Yan, C. Butterfield, G. Jackson, J. Harper, G. Tamvakopoulos, and M. A. Moses. 2000. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc. Natl. Acad. Sci. USA 97: 3884-3889. (Pubitemid 30226056)
32. Hiraoka, N., E. Allen, I. J. Apel, M. R. Gyetko, and S. J. Weiss. 1998. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95: 365-377. (Pubitemid 28507325)
33. Bergers, G., R. Brekken, G. McMahon, T. H. Vu, T. Itoh, K. Tamaki, K. Tanzawa, P. Thorpe, S. Itohara, Z. Werb, and D. Hanahan. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2: 737-744. (Pubitemid 30768157)
34. Deryugina, E. I., and Quigley, J. P. 2006. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25: 9-34.
35. Nakamura, T., K. Matsumoto, A. Kiritoshi, Y. Tano, and T. Nakamura. 1997. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res. 57: 3305-3313. (Pubitemid 27351751)
36. Balkwill, F. 2004. Cancer and the chemokine network. Nat. Rev. 4: 540-550.
37. Menten, P., A. Saccani, C. Dillen, A. Wuyts, S. Struyf, P. Proost, A. Mantovani, J. M. Wang, and J. Van Damme. 2002. Role of the autocrine chemokines MIP-1α and MIP-1β in the metastatic behavior of murine T cell lymphoma. J. Leukocyte Biol. 72: 780-789. (Pubitemid 36277850)
38. Yang, X., P. Lu, Y. Ishida, W. A. Kuziel, C. Fujii, and N. Mukaida. 2006. Attenuated liver tumor formation in the absence of CCR2 with a concomitant reduction in the accumulation of hepatic stellate cells, macrophages and neovascularization. Int. J. Cancer 118: 335-345. (Pubitemid 41779072)
39. Lu, P., Y. Nakamoto, Y. Nemoto-Sasaki, C. Fujii, H. Wang, M. Hashii, Y. Ohmoto, S. Kaneko, K. Kobayashi, and N. Mukaida. 2003. Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas. Am. J. Pathol. 162: 1249-1258. (Pubitemid 36350669)
40. Combadiere, C., S. K. Ahuja, H. L. Tiffany, and P. M. Murphy. 1996. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1α, MIP-1β, and RANTES. J. Leukocyte Biol. 60: 147-152. (Pubitemid 26248894)
41. He, J., Y. Chen, M. Farzan, H. Choe, A. Ohagen, S. Gartner, J. Busciglio, X. Yang, W. Hofmann, W. Newman, et al. 1997. CCR3 and CCR5 are coreceptors for HIV-1 infection of microglia. Nature 385: 645-649. (Pubitemid 27087579)
42. Reichel, C. A., A. Khandoga, H. J. Anders, D. Schlondorff, B. Luckow, and F. Krombach. 2006. Chemokine receptors Ccr1, Ccr2, and Ccr5 mediate neutrophil migration to postischemic tissue. J. Leukocyte Biol. 79: 114-122.
43. van Deventer, H. W., W. O'Connor, Jr., W. J. Brickey, R. M. Aris, J. P. Ting, and J. S. Serody. 2005. C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis. Cancer Res. 65: 3374-3379.
44. Orr, F. W., H. H. Wang, R. M. Lafrenie, S. Scherbarth, and D. M. Nance. 2000. Interactions between cancer cells and the endothelium in metastasis. J. Pathol. 190: 310-329. (Pubitemid 30141377)
45. Carmeliet, P., and R. K. Jain. 2000. Angiogenesis in cancer and other diseases. Nature 407: 249-257.
46. Yancopoulos, G. D., S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand, and J. Holash. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248.
47. Yoshida, S., M. Ono, T. Shono, H. Izumi, T. Ishibashi, H. Suzuki, and M. Kuwano. 1997. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor α-dependent angiogenesis. Mol. Cell. Biol. 17: 4015-4023. (Pubitemid 27281877)
48. Cao, Y., P. Linden, D. Shima, F. Browne, and J. Folkman. 1996. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J. Clin. Invest. 98: 2507-2511. (Pubitemid 26415071)
49. Kalluri, R., and M. Zeisberg. 2006. Fibroblasts in cancer. Nat. Rev. 6: 392-401.
50. Orimo, A., P. B. Gupta, D. C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V. J. Carey, A. L. Richardson, and R. A. Weinberg. 2005. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348. (Pubitemid 40692295)
51. Petit, I., D. Jin, and S. Rafii. 2007. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol. 28: 299-307. (Pubitemid 46963141)
52. Quan, T. E., S. Cowper, S. P. Wu, L. K. Bockenstedt, and R. Bucala. 2004. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int. J. Biochem. Cell Biol. 36: 598-606. (Pubitemid 38316817)
53. Schmidt, M., G. Sun, M. A. Stacey, L. Mori, and S. Mattoli. 2003. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171: 380-389. (Pubitemid 36745311)
54. Abe, R., S. C. Donnelly, T. Peng, R. Bucala, and C. N. Metz. 2001. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166: 7556-7562. (Pubitemid 32525636)